RNA, U6 small nuclear 209, pseudogene (RNU6-209P)

**RNA, U6 small nuclear 209, pseudogene (RNU6-209P)** is a non-coding RNA gene classified as a processed pseudogene in humans. This gene is a derivative of the functional U6 small nuclear RNA (snRNA) gene, but due to mutations or lack of required regulatory elements, it does not produce a functional RNA product. U6 snRNAs are core RNA components of the spliceosome and play a central role in pre-mRNA splicing, but RNU6-209P, as a pseudogene, is not functionally involved in this process[1][2][3]. Pseudogenes like RNU6-209P can arise from retrotransposition events or gene duplication followed by disabling mutations, and they are generally considered non-functional. There is no evidence supporting a role for RNU6-209P as a therapeutic target, nor any associations with disease, drug interactions, or biomarker use[1][3]. **Key points:** - This entry refers to a *pseudogene*, not an active protein, RNA, or drug target[1][3]. - It is *not* considered a therapeutic or diagnostic target. - The entry is “incorrect” as a drug target due to its pseudogene status, lack of biological function, and non-involvement in disease pathways. **Supporting notes:** - The canonical U6 snRNA (not the pseudogene) is highly conserved and essential for spliceosome function, but pseudogenes like RNU6-209P are usually “dead copies” and do not contribute to cellular biology in a meaningful way in current research[2][3]. - No drugs, biomarkers, mechanisms of action, or safety issues are associated with this pseudogene.

Other names

RNU6-209PRNA, U6 small nuclear 209, pseudogene